🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11325+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11325 recruiting trials

NARecruitingNCT06551649

Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation

👨‍⚕️ Ornella Parolini, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 2 sites📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06543381

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

👨‍⚕️ Amandeep Salhotra, MD, City of Hope Medical Center📍 2 sites📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06642792

A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma

👨‍⚕️ Wenting Li, MD, Akeso📍 1 site📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06517888

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

👨‍⚕️ Aaron Tward, MD, Eli Lilly and Company📍 4 sites📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06708663

HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours

👨‍⚕️ Lin Shen, Peking University Cancer Hospital & Institute📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06823427

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

🏥 Mabwell (Shanghai) Bioscience Co., Ltd.📍 2 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT05971758

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

🏥 University of California, Los Angeles📍 1 site📅 Started Jan 2025View details ↗
EARLY_Phase 1RecruitingNCT06849609

A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

🏥 Hong Chen📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06674811

Biomarkers of Resiliency In Childhood Cancer Surgery

👨‍⚕️ Stephanie Polites, M.D., M.P.H., Mayo Clinic📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT06055257

Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible

👨‍⚕️ Ben Safa, MD, Sunnybrook Health Sciences Centre📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT05814432

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS

👨‍⚕️ Daiane F Dalla Lana, PhD, Federal University of Health Science of Porto Alegre📍 5 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06771687

High Intensity Interval Training in Patients With a Right Ventricle to Pulmonary Artery Conduit

👨‍⚕️ Beatrijs Bartelds, MD, PhD, Erasmus Medical Center📍 2 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06687772

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

👨‍⚕️ Amanda F Cashen, M.D., Washington University School of Medicine📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06756061

Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity

🏥 Byung-Sik Cho📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06556615

Health Related Quality of Life (HrQoL) in Classical Homocystinuria (CBS Deficiency)

🏥 University Children's Hospital, Zurich📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06950892

Remote Sputum Collection in Cystic Fibrosis

👨‍⚕️ Gina Hong, MD, University of Pennsylvania📍 3 sites📅 Started Jan 2025View details ↗
RecruitingNCT06676046

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

👨‍⚕️ Marcelo J Amar, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Jan 2025View details ↗
NAEnrolling by InvitationNCT06892236

Preparation of IPSC for Cell Gene Editing for the Treatment of AATD

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT07500103

Spatiotemporal Entrainment Neuromodulation Targeting Cerebello-Cerebral Circuits to Enhance Cognitive and Social Rehabilitation in Cerebellar Diseases

👨‍⚕️ Maria Leggio, MD, PhD, I.R.C.C.S. Fondazione Santa Lucia📍 2 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06758037

Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients with DLBCL Intolerant to Chemotherapy

🏥 First Affiliated Hospital of Ningbo University📍 1 site📅 Started Jan 2025View details ↗
← PreviousPage 175 of 567Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →